4.5 Article

Identification of T-gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans

Journal

VACCINE
Volume 28, Issue 23, Pages 3977-3989

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2010.03.028

Keywords

Toxoplasma gondii; Vaccine; HLA Class 1 bound peptides

Funding

  1. Fin Charity Trust
  2. Dominique Cornwell and Peter Mann Family Foundation
  3. Intervet/Schering Plough
  4. Toxoplasmosis Research Institute
  5. DMID-NIAID [U01 A177887]
  6. NIH, NIAID
  7. The Research to Prevent Blindness Foundation

Ask authors/readers for more resources

Toxoplasma gondii is an intracellular parasite that causes severe neurologic and ocular disease in immune-compromised and congenitally infected individuals. There is no vaccine protective against human toxoplasmosis. Herein, immunization of L-d mice with HF10 (HPGSVNEFDF) with palmitic acid moieties or a monophosphoryl lipid A derivative elicited potent IFN-gamma production from L-d-restricted CD8(+) T cells in vitro and protected mice. CD8(+) T cell peptide epitopes from T. gondii dense granule proteins GRA 3, 6, 7, and Sag 1, immunogenic in humans for HLA-A02(+), HLA-A03(+), and HLA-B07(+) cells were identified. Since peptide repertoire presented by MHC class I molecules to CD8(+) T cells is shaped by endoplasmic reticulum-associated aminopeptidase (ERAAP), polymorphisms in the human ERAAP gene ERAP1 were studied and associate with susceptibility to human congenital toxoplasmosis (p <0.05). These results have important implications for vaccine development. (C) 2010 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available